L&L Biopharma

Company Deals

L&L Biopharma Completes Series B Financing for Tumor Immunotherapy Development

Fineline Cube Mar 21, 2023

Shanghai-based tumor immunotherapy developer L&L Biopharma Co., Ltd has announced the completion of a Series...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod